Finding a needle in a haystack: The hidden costs of asymptomatic testing in a low incidence setting

By sjmartinez • October 25, 2022

Srinivasan V, Gohil SK, Abeles SR, Yokoe DS, Cohen SH, Ramirez-Avila L, Prabaker KK, de St Maurice AM. Finding a needle in a haystack: The hidden costs of asymptomatic testing in a low incidence setting. Infect Control Hosp Epidemiol. 2022 Oct;43(10):1525-1526. doi: 10.1017/ice.2021.288. Epub 2021 Jun 24. PMID: 34162461; PMCID: PMC8280392.

Tags: Infectious Diseases, Publications

Antimicrobial use before and during COVID-19: data from 108 Veterans Affairs medical centers

Goetz MB, Willson T, Rubin MA, Stevens VW, Graber CJ. Antimicrobial use before and during COVID-19: data from 108 Veterans Affairs medical centers. Antimicrob Steward[...]

Rapid and comprehensive detection of viral antibodies and nucleic acids via an acoustofluidic integrated molecular diagnostics chip: AIMDx

Qian J, Xia J, Chiang S, Liu JF, Li K, Li F, Wei F, Aziz M, Kim Y, Go V, Morizio J, Zhong R, He[...]

Mpox primer for clinicians: what makes the difference in 2024?

Abdel-Rahman SM, Bayıcı BZ, Keske Ş, Kuşkucu M, Özsürekçi Y, Rimoin AW, Rodriguez-Morales AJ, Ergönül Ö. Mpox primer for clinicians: what makes the difference in[...]